# A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice

> **NCT06008691** · — · RECRUITING · sponsor: **Fondazione Italiana Linfomi - ETS** · enrollment: 1500 (estimated)

## Conditions studied

- Non-Hodgkin Lymphoma, B-cell

## Interventions

- **DRUG:** "novel" MAB (alone or in combination)

## Key facts

- **NCT ID:** NCT06008691
- **Lead sponsor:** Fondazione Italiana Linfomi - ETS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-27
- **Primary completion:** 2038-10
- **Final completion:** 2038-10
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2025-12-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06008691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06008691, "A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06008691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*